الوضع الليلي
6:17:3 
2021-12-23 
1641
The Food and Drug Administration (FDA) on Wednesday authorized a new COVID-19 treatment from Pfizer, the first pill to treat the virus to become available.
The pill, known as Paxlovid, is seen as a major step forward in the fight against the virus, with trials showing it reduced the risk of hospitalization or death by 89 percent in high-risk patients.
The treatment is expected to be in short supply to begin with, though, leading to calls for the Biden administration to do more to boost supply.
"Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic," said Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research. "This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19."
The fact that Paxlovid is a pill, rather than previous treatments which required injections, should make it more accessible and easier to take. It has also shown very promising results in trials in reducing the worst outcomes from the virus, putting the country on the path to defanging COVID-19.
But experts are warning that supply will be constrained in the short term, and they have called on the Biden administration to take actions like enlisting other manufacturers to help make it.
The company has said about 180,000 courses will be available this year. That is not a sufficient amount given there are more than 100,000 cases of COVID-19 every day just in the U.S.
Reality Of Islam |
|
A study of
Researchers
MIT enginee
9:3:43
2018-11-05
10 benefits of Marriage in Islam
7:5:22
2019-04-08
benefits of reciting surat yunus, hud &
9:45:7
2018-12-24
advantages & disadvantages of divorce
11:35:12
2018-06-10
6:0:51
2018-10-16
4:26:43
2022-02-21
9:39:36
2022-12-28
2:5:14
2023-01-28
7:0:55
2022-05-17
5:57:34
2023-03-18
7:32:24
2022-02-14
9:42:16
2022-10-19
5:41:46
2023-03-18
| LATEST |
HOME
